CCAB Centro Clinico Academico Braga Associacao — Clinical Trial Site

198 Registered trials

88 Currently recruiting

Organisation

CCAB Centro Clinico Academico Braga Associacao

Location

Braga, Portugal

Identifier

ORG-100041983

Address

Lugar De Sete Fontes S Victor, 4710-243, Portugal

Departments

-
#1802:Serviço de Cardiologia
#2462: Serviço de Neurologia
#3254: Serviço de Reumatologia
#3605:Serviço Reumatologia
#5701: Serviço Neurologia
035101: Pediatria
1801: Serviço Neurologia
2700: Serviço Neurologia
2801; Internal Medicine
3254; Serviço de Reumatologia
3301: Serviço de Dermatologia
35109: Oncologia
3605:Serviço de Reumatologia
5804: Dermatologia
7262: Neurologia
9229: Serviço de Dermatologia
Allergology
Cardiologia
Cardiology
Cardiology Department
CCAB - Centro Clinico Académico Braga Associação
Centro Clínico Académico
Centro Clínico Académico - Braga
Centro Clínico Académico - Braga, Associação (2CA-Braga)
Cirurgia Geral
Clinical Research Unit
Department of Nephrology
Department Oncologia Médica
Dermatology
Gastroenterology
Gastroenterology Department
Gastroenterology service
Gastrology
Hematologia Clínica
Hematology
Hematology Department
Hospital Braga
Hospital de Braga
Hospital de Braga ( #1)
Infectious Diseases
Intensive care medicine
Internal Medicine
Medical Oncology
Medical Oncology Service
n/a
NA
Nefrology
Nephrology
Nephrology Department
Neurologia
Neurology
Neurology Department
Neurology Unit
Neuroradiology
Not applicable
Oncologia
Oncologia Médica
Oncology
Oncology Department
Oncology Service
Otorhinolaryngology Service
pediactric
Pediatria
Pediatric
Pediatric endocrinology and diabetology
Pediatrics Service (Pediatric Gastroenterology Unit)
Pneumologia
Pneumology
Psychiatry
Psychiatry Service
PT10007: Unidade de Investigação Clínica
PT30006:Unidade de Cuidados Intensivos
Pulmonology
reumathology
Rheumatology
Rheumatology Department
Senology
Servico de Cardiologia
Serviço de Endocrinologia
Serviço de Gastrenterologia
Serviço de Gastroenterologia
Serviço de Medicina Interna
Serviço de Nefrologia
Serviço de Neurologia
Serviço de Oncologia
Serviço de Oncologia Médica
Serviço de Pediatria
Serviço de Pneumologia
Serviço de Reumatologia
Serviço de Urologia
Serviço Dermatologia
Serviço Neurologia
ULS de Braga, E.P.E. – Centro Clínico Académico (2CA)
Unidade de Investigação Clínica
Unidade Local Saude Braga
Urology service

Clinical trials at this site (198)

Search interface

A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Juvenile psoriatic arthritis (jPsA) 5 2024-10-29
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CO… Recruiting

2023-508760-29-00 Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) 5 2024-10-21
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chron… Recruiting

2023-508338-33-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2024-10-01
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Trastuzumab Deruxtecan (T-DXd) for Subjects with Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC0 Breast Cancer… Recruiting

2023-505616-38-00 Unresectable and/or Metastatic HER2-low or HER2 Immunoh 4 2024-09-04
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 Bullous pemphigoid 3 2024-08-22
MODAFIMS: An open-label, single-center clinical trial to evaluate predictors of response to MODAFinil in the treatment of cognitive deficits… Recruiting

2022-501414-53-00 Multiple sclerosis 4 2024-08-21
Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Tri… Recruiting

2024-511085-37-00 Obsessive-compulsive disorder (OCD) 4 2024-08-19
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on… Recruiting

2022-502135-19-00 Calcific Aortic Valve Stenosis 4 2024-07-18
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
Study to learn about the safety of fazirsiran and if it can help people with alpha-1 antitrypsin liver disease with mild liver scarring (fib… Recruiting

2023-504198-19-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2024-04-18
Bomedemstat vs Best Available Therapy (BAT) for Essential Thrombocythemia Recruiting

2023-504865-21-00 Essential Thrombocythemia patients who have an inadequa 5 2024-04-15
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants with Moderately to Severely Active Crohn’s Disease Recruiting

2023-504735-41-00 Moderately to Severely Active Crohn's Disease 5 2024-03-05
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Newly Diagnosed Multiple Myeloma (NDMM) 5 2023-09-29
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting

2022-501943-34-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2023-06-27
A study with eptinezumab in children and adolescents (6 to 17 years) with chronic or episodic migraine (REJOIN) Recruiting

2022-502917-27-00 Migraine 5 2023-03-07
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN). Recruiting

2023-507233-19-00 Treatment of IgAN 10 2023-02-16
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants with Ulcerative Colitis or Crohn’s Disease (SHINE-ON) Recruiting

2023-506239-14-00 Crohn’s Disease 5 2022-12-13